Director, Neuropsychiatry Discovery Translational Biomarker Lead

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Discovery & Pre-Clinical/Clinical Development

Job Sub Function:
Translational Discovery & Development Biomarkers

Job Category:
Scientific/Technology

All Job Posting Locations:
Cambridge, Massachusetts, United States of America, San Diego, California, United States of America, Spring House, Pennsylvania, United States of America, Titusville, New Jersey, United States of America

Job Description:

Johnson and Johnson is recruiting for a Director, Neuropsychiatry Discovery Translational Biomarker Lead to be located in La Jolla, CA, Titusville, NJ, Spring House, PA, or Cambridge, MA. 

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Neuroscience team tackles the world’s toughest brain health challenges including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, epilepsy, major depressive disorder, bipolar disorder, schizophrenia, and autism.

This patient-focused team helps address some of the most complex diseases of our time.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine
 

The Neuroscience Precision Measures Team is an integrated group of scientists that supports the mission to deliver precision therapeutics to patients with CNS disorder in the areas of neuropsychiatry, neurodegeneration and ophthalmology.  The team is composed of disease experts, biomarker scientists, computational biologists, and experts in imaging and digital health, partnering closely with the Neuroscience Discovery and Development organizations to enable advancement of our industry leading pipeline of novel mechanisms. 

The Precision Measures team advances measurement based on human data from fluids, tissues, high-dimensional biology, and neuroimaging to support the end-to-end portfolio.

Together with our partners, the PM group will provide the key learnings/insights on the next wave of novel therapies.

Precision Measures has a broad remit stretching from support of discovery with human data to support target selection, through development of novel decision-making biomarkers for early phase clinical trials, biomarker support of regulatory filings, post-market publica...